Cardiovascular drugs in older people

Australian Prescriber

Volumn 36, Issue 6, 2013, Pages 190-194

  Naganathan, Vasi ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Aged 80 and over; Atrial fibrillation; Heart failure; Hypertension

Indexed keywords

ALDOSTERONE ANTAGONIST; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARDIOVASCULAR AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ANTICOAGULATION; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; COMORBIDITY; DISEASE ASSOCIATION; DRUG BLOOD LEVEL; DRUG CHOICE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; ELDERLY CARE; EVIDENCE BASED MEDICINE; FRAIL ELDERLY; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; HYPERTENSION; LIFE EXPECTANCY; PRACTICE GUIDELINE; PRESCRIPTION; RISK REDUCTION; VERY ELDERLY;

EID: 84888795364     PISSN: 03128008     EISSN: None     Source Type: Journal    
DOI: 10.18773/austprescr.2013.077     Document Type: Article

References (9)

1. Nair BR. Evidence based medicine for older people: available, accessible, acceptable, adaptable? Australas J Ageing 2002;21:58-60.
2. Burgess CL, Holman CD, Satti AG. Adverse drug reactions in older Australians, 1981-2002. Med J Aust 2005;182:267-70.
3. Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008;358:1887-98.
4. National Heart Foundation of Australia (National Blood Pressure and Vascular Disease Advisory Committee). Guide to management of hypertension 2008. Updated December 2010. National Heart Foundation; 2010.
5. Masoudi FA, Havranek EP, Wolfe P, Gross CP, Rathore SS, Steiner JF, et al. Most hospitalized older persons do not meet the enrollment criteria for clinical trials in heart failure. Am Heart J 2003;146:250-7.
6. SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293-302.
7. MERIT-HF Investigators. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999;353:2001-7.
8. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, et al; Randomized Aldactone Evaluation Study Investigators. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999;341:709-17.
9. NPS MedicineWise. Good anticoagulant practice. Medicinewise News 2013 Feb 4. www.nps.org.au/publications/health-professional/ medicinewise-news/2013/good-anticoagulant-practice [cited 2013 Nov 7]